Translate this page into:
Editorial
doi:
10.4103/2278-330X.181623
Selected current data on metronomic therapy (and its promise) from India
1
Department of Precision Oncology, Asian Cancer Institute, Sion East, Mumbai, Maharashtra
2
Department of Oncology, Deenanath Mangeshkar Hospital, Erandwane, Pune, Maharashtra
*Corresponding author: Dr. Parikh M. Parikh. purvish1@gmail.com
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
References
- Patil V, Noronha V, Krishna V, Joshi A, Prabhash K. Oral metronomic chemotherapy in recurrent, metastatic and locally advanced head and neck cancers. Clin Oncol (R Coll Radiol) 2013;25:388.
- Patil V, Karpe A, Noronha V, Joshi A, Muddu V, Bhattacharjee A, et al. Efficacy of second-line erlotinib in patients postprogression of first-line chemotherapy in head and neck cancers. Indian J Cancer 2015;52:629-31.
- Noronha V, Joshi A, Marfatia S, Patil V, Juvekar S, Arya S, et al. Health-related quality of life in patients with metastatic, relapsed, or inoperable squamous cell carcinoma of the head and neck in India. Support Care Cancer 2016;24:1595-602.
- Patil VM, Noronha V, Joshi A, Muddu VK, Dhumal S, Bhosale B, et al. A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck. Oral Oncol 2015;51:279-86.
- Pai PS, Vaidya AD, Prabhash K, Banavali SD. Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A matched-pair analysis. Indian J Cancer 2013;50:135-41.
- Majumder D, Mukherjee A. Mathematical modelling of toxicity-related trade-offs in metronomic chemotherapy. IET Syst Biol 2007;1:298-305.
- Noronha V, Tsomo U, Jamshed A, Hai M, Wattegama S, Baral R, et al. A fresh look at oncology facts on south central Asia and SAARC countries. South Asian J Cancer 2012;1:1-4.
- André N, Pasquier E. Metronomics in low and middle income countries: India showing the way! Indian J Cancer 2013;50:112-4.
- Bouche G, André N, Banavali S, Berthold F, Berruti A, Bocci G, et al. Lessons from the fourth metronomic and anti-angiogenic therapy meeting, 24-25 June 2014, Milan. Ecancermedicalscience 2014;8:463.
- Tandon N, Banavali S, Menon H, Gujral S, Kadam PA, Bakshi A. Is there a role for metronomic induction (and maintenance) therapy in elderly patients with acute myeloid leukemia? A literature review. Indian J Cancer 2013;50:154-8.
- Malik PS, Raina V, André N. Metronomics as maintenance treatment in oncology: Time for chemo-switch. Front Oncol 2014;4:76.
- Browder T, Butterfield CE, Kräling BM, Shi B, Marshall B, O′Reilly MS, et al. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000;60:1878-86.
- Kerbel RS, Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer 2004;4:423-36.
- Noronha V, Krishna MV, Patil V, Joshi A, Banavali SD, Prabhash K. Metronomic therapy: Chemotherapy revisited. Indian J Cancer 2013;50:142-8.
- Bahl A, Bakhshi S. Metronomic chemotherapy in progressive pediatric malignancies: Old drugs in new package. Indian J Pediatr 2012;79:1617-22.
- Agrawal A, Purandare N, Shah S, Puranik A, Banavali S, Rangarajan V. Response assessment in metronomic chemotherapy: RECIST or PERCIST? Indian J Nucl Med 2014;29:74-80.
- Sondhi V, Arun Kurkure P, Jalali R, Rangarajan V, Sridhar E, Medhi S, et al. Complete remission and long-term survival in a child with relapsed medulloblastoma with extensive osteosclerotic bony metastasis with a novel metronomic chemobiological approach. J Pediatr Hematol Oncol 2012;34:e195-8.
- Parikh PM, Prabhash K, Bhattacharyya GS, Sirohi B, Rajappa S, Verma A, et al. Ignore molecular oncology at your peril. Indian J Cancer 2014;51:150-3.